Investors

2-3-1

Investment Opportunity

Biotherapy Services Ltd. is a private limited company approved under the UK Enterprise Investment Scheme (EIS). There is now an opportunity to join our current shareholder list by equity investment into the company. For more information please email: please email info@biotherapyservices.com

In  August 2018, the Company was granted a MIA/(IMP) Licence by the MHRA to manufacture the RAPID™ Biodynamic Haematogel wound care treatment for clinical trial patients.

 

In parallel, the MHRA have granted Biotherapy Services Ltd. a “Specials” Licence for the provision of the RAPID™ Biodynamic Haematogel wound care treatments so that the clinicians can prescribe and use on a compassionate usage basis

Request Investor Information

There is now a unique opportunity to join our current shareholder list by equity investment into the company.

For further information about becoming an investor, please email info@biotherapyservices.com